To Sleep or Not To Sleep: A Systematic Review of the Literature of Pharmacological Treatments of Insomnia in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

1 Cognition, Schizophrenia, & Imaging Laboratory, Department of Psychosis Studies, the Institute of Psychiatry , King's College, London, United Kingdom .
Journal of child and adolescent psychopharmacology (Impact Factor: 2.93). 11/2013; 23(10). DOI: 10.1089/cap.2013.0059
Source: PubMed


This systematic review assessed current evidence on sleep medication for attention-deficit/hyperactivity disorder (ADHD) patients, to establish appropriate guidance for clinicians faced with prescribing such medications.

Five articles (based on four pharmacological compounds) out of a total 337 were identified as evidence to guide pharmacological treatment of ADHD-related sleep disorders. Data regarding participant characteristics, measures of ADHD diagnosis, measures of sleep, and outcome data were extracted.

Zolpidem and L-theanine both displayed a poor response in reducing sleep latency and increasing total sleep time, however L-theanine did produce an increase in sleep efficiency. Zolpidem produced high levels of side effects, leading to the largest dropout rate of all five studies. Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency.

There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.

30 Reads

  • No preview · Article · Jan 2014 · Expert Review of Neurotherapeutics
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sleep problems are common in attention-deficit/hyperactivity disorder (ADHD) to the extent that they mimic or exacerbate daytime symptoms expression. In this review, we advocate the need for a better understanding of sleep alterations in youths with ADHD and their impact on neurobehavioral functions including learning, memory and emotional regulation. An in-depth exploration of existing data showed that although extensively studied, the actual nature of sleep problems in ADHD and their effects on daytime behavior are still less well understood. Important issues, among which developmental changes in sleep architecture and role of subtle sleep electroencephalogram signatures, are generally neglected. Future research of sleep effects on behavior in ADHD would benefit from considering developmental aspects and links between brain activation patterns during sleep and wake.
    Full-text · Article · Feb 2014 · Expert Review of Neurotherapeutics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sleep problems represent a real and troubling aspect of the lives of many children with NDD. As with TD children, the most common sleep problem among children with NDD is behavioral insomnia. Prevalence rates of sleep problemsin general range between 50% and 95% for children with NDD. Given that poor sleep in children with NDD has been associated with impairments in daytime functioning, decreased quality of life for the children, increased NDD symptoms and morbidity, and negative effects on caregivers health and parenting abilities, these high rates are concerning and underscore the need for appropriate screening, diagnostic evaluation, and management. Behavioral interventions have considerable empiric support and should be recommended as first-line treatment of sleep problems in this population. Additional research is needed to establish the effectiveness of specific behavioral strategies, including psychoeducation, healthy sleep practices, and techniques, such as faded bedtime with response cost (FBRC) or extinction, for treating behavioral insomnia in children with NDD.
    No preview · Article · Jun 2014 · Sleep Medicine Clinics
Show more